|

Consolidative immunotherapy Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 3

Top Sponsors

  • Sun Yat-sen University3

Indications

  • Lung Cancer3
  • Cancer3
  • Locally Advanced Non-Small Cell Lung Cancer2
  • Concurrent Chemoradiotherapy1
  • Immunotherapy1

Other3 trials

Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI
Phase 3
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
Phase 3
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.